See alpha-lipoic acid. As direct supplement limited data. Antioxidant properties similar. Hypoglycaemia risk.
Reduced form of alpha-lipoic acid. Endogenously generated from ALA by lipoamide dehydrogenase. More potent antioxidant than oxidised ALA. Generally taken as ALA which converts to DHLA in vivo.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)